Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

Eligibility criteria

Qualifiers

Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder

Prior abdominal imaging

Disqualifiers

History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)

Trial design

Treatments tested in this trial

  • Non-Interventional Study

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators